JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS)

CNY 9.85

(0.92%)

Total Liabilities Summary of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest annual total liabilities in 2023 was 2.56 Billion CNY , up 22.76% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 2.28 Billion CNY , down -13.85% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported annual total liabilities of 2.08 Billion CNY in 2022, up 10.88% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported annual total liabilities of 1.88 Billion CNY in 2021, up 1.59% from previous year.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported quarterly total liabilities of 2.28 Billion CNY for 2024 Q2, down -13.85% from previous quarter.
  • JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported quarterly total liabilities of 2.26 Billion CNY for 2024 Q3, down -0.62% from previous quarter.

Annual Total Liabilities Chart of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Historical Annual Total Liabilities of JiangSu WuZhong Pharmaceutical Development Co., Ltd. (2023 - 1996)

Year Total Liabilities Total Liabilities Growth
2023 2.56 Billion CNY 22.76%
2022 2.08 Billion CNY 10.88%
2021 1.88 Billion CNY 1.59%
2020 1.85 Billion CNY 18.97%
2019 1.55 Billion CNY -29.56%
2018 2.2 Billion CNY 29.74%
2017 1.7 Billion CNY -25.01%
2016 2.27 Billion CNY -10.6%
2015 2.54 Billion CNY -11.8%
2014 2.88 Billion CNY 0.61%
2013 2.86 Billion CNY -13.26%
2012 3.3 Billion CNY 19.47%
2011 2.76 Billion CNY 41.44%
2010 1.95 Billion CNY 75.46%
2009 1.11 Billion CNY -3.84%
2008 1.15 Billion CNY 1.59%
2007 1.13 Billion CNY -14.06%
2006 1.32 Billion CNY 8.86%
2005 1.21 Billion CNY 25.41%
2004 971.12 Million CNY 11.65%
2003 869.77 Million CNY 122.35%
2002 391.16 Million CNY 16.81%
2001 334.88 Million CNY 33.91%
2000 250.07 Million CNY 17.39%
1999 213.01 Million CNY 2.4%
1998 208.02 Million CNY 71.98%
1997 120.95 Million CNY 4.71%
1996 115.52 Million CNY 0.0%

Peer Total Liabilities Comparison of JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Beijing Tiantan Biological Products Co., Ltd. 1.33 Billion CNY -91.956%
Jinyu Bio-technology Co., Ltd. 1.21 Billion CNY -110.319%
Vcanbio Cell & Gene Engineering Corp., Ltd 1.61 Billion CNY -58.793%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 6.65 Billion CNY 61.493%
Zhejiang Ausun Pharmaceutical Co., Ltd. 809.99 Million CNY -216.166%
DaShenLin Pharmaceutical Group Co., Ltd. 16.17 Billion CNY 84.163%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 2.79 Billion CNY 8.463%
GuiZhou SanLi Pharmaceutical Co.,Ltd 1.17 Billion CNY -117.928%
Pulike Biological Engineering, Inc. 538.33 Million CNY -375.714%
Beijing Konruns Pharmaceutical Co.,Ltd. 418.43 Million CNY -512.021%
Shanghai Hile Bio-Technology Co., Ltd. 482.95 Million CNY -430.26%
Qingdao Vland Biotech INC. 1.15 Billion CNY -122.061%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 1 Billion CNY -155.31%
Aurisco Pharmaceutical Co.,Ltd. 607.02 Million CNY -321.882%
Zhejiang East Asia Pharmaceutical Co., Ltd. 1.32 Billion CNY -92.831%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 1.9 Billion CNY -34.702%
Mabwell (Shanghai) Bioscience Co., Ltd. 1.88 Billion CNY -36.089%
Beijing Hotgen Biotech Co., Ltd. 202.56 Million CNY -1164.27%
Assure Tech (Hangzhou) Co., Ltd. 683.82 Million CNY -274.5%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 1.28 Billion CNY -98.957%
Cabio Biotech (Wuhan) Co., Ltd. 117.6 Million CNY -2077.634%
Shanghai Shen Lian Biomedical Corporation 86.92 Million CNY -2846.093%
Nanjing Vazyme Biotech Co., Ltd. 1.69 Billion CNY -51.042%
Shandong Kexing Bioproducts Co,.Ltd 1.4 Billion CNY -82.885%
Shanghai Junshi Biosciences Co., Ltd. 3.83 Billion CNY 33.288%
Shanghai Model Organisms Center, Inc. 260.98 Million CNY -881.256%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 1.23 Billion CNY -108.066%
Xiamen Amoytop Biotech Co., Ltd. 479.68 Million CNY -433.877%
Novogene Co., Ltd. 1.12 Billion CNY -128.535%
Shanghai ZJ Bio-Tech Co., Ltd. 241.66 Million CNY -959.72%
Chengdu Olymvax Biopharmaceuticals Inc. 681.84 Million CNY -275.591%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 308.14 Million CNY -731.088%
Shanghai Haohai Biological Technology Co., Ltd. 1.07 Billion CNY -138.319%
Jiangsu Bioperfectus Technologies Co., Ltd. 501.3 Million CNY -410.848%
Jiangsu Aidea Pharmaceutical Co., Ltd. 621.02 Million CNY -312.37%
Chengdu Easton Biopharmaceuticals Co., Ltd. 743.33 Million CNY -244.519%
Sinocelltech Group Limited 3.21 Billion CNY 20.443%
Wuhan Keqian Biology Co.,Ltd 833.59 Million CNY -207.216%
Shanghai Allist Pharmaceuticals Co., Ltd. 394.21 Million CNY -549.624%
Anhui Huaheng Biotechnology Co., Ltd. 2.14 Billion CNY -19.414%
Youcare Pharmaceutical Group Co., Ltd. 2.31 Billion CNY -10.689%
Jiangsu gdk Biotechnology Co., Ltd. 260.51 Million CNY -883.008%
Beijing Kawin Technology Share-Holding Co., Ltd. 663.01 Million CNY -286.256%
Hangzhou Biotest Biotech Co.,Ltd. 158.82 Million CNY -1512.464%